Your browser doesn't support javascript.
loading
Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy.
de Wit, Ronald; Powles, Thomas; Castellano, Daniel; Necchi, Andrea; Lee, Jae-Lyun; van der Heijden, Michiel S; Matsubara, Nobuaki; Bamias, Aristotelis; Fléchon, Aude; Sternberg, Cora N; Drakaki, Alexandra; Yu, Evan Y; Zimmermann, Annamaria H; Long, Amanda; Walgren, Richard A; Gao, Ling; Bell-McGuinn, Katherine M; Petrylak, Daniel P.
Afiliação
  • de Wit R; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Powles T; Barts Cancer Institute, Queen Mary University of London, UK.
  • Castellano D; Hospital 12 de Octubre, I + 12 Research Institute, Madrid, Spain.
  • Necchi A; Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy.
  • Lee JL; Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • van der Heijden MS; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Matsubara N; National Cancer Center Hospital East, Chiba, Japan.
  • Bamias A; National and Kapodistrian University of Athens, Athens, Greece.
  • Fléchon A; Centre Léon Bérard, Lyon, France.
  • Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Sandra and Edward Meyer Cancer Center, New York, NY, USA.
  • Drakaki A; University of California Los Angeles, Los Angeles, CA, USA.
  • Yu EY; University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Zimmermann AH; Eli Lilly and Company, Indianapolis, IN, USA.
  • Long A; Eli Lilly and Company, Indianapolis, IN, USA.
  • Walgren RA; Eli Lilly and Company, Indianapolis, IN, USA.
  • Gao L; Eli Lilly and Company, Indianapolis, IN, USA.
  • Bell-McGuinn KM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Petrylak DP; Yale University School of Medicine, New Haven, CT, USA.
Br J Clin Pharmacol ; 88(7): 3182-3192, 2022 07.
Article em En | MEDLINE | ID: mdl-35029306

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda